Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts

NCT05369975 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

113

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation in Highly Sensitized Patients

Interventions

DRUG: Imlifidase
OTHER: Normal Transplantation Routine

Sponsor

Hansa Biopharma AB